951744-79-9

Upstream product

• 118753-70-1 N-(tert-butyloxycarbonyl)bis(2-chloroethyl)amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 1093214-72-2 piperidine-1,4,4-tricarboxylic acid 1-tert-butyl 4,4-dibenzyl ester 
• 124-38-9 carbon dioxide 
• 177990-33-9 4-Benzyloxycarbonyl-1-tert-butoxycarbonylpiperidine 

Downstream Products

• 1093214-73-3 piperidine-1,4,4-tricarboxylic acid 1-tert-butyl 4-benzyl 4-(3,3-dimethyl-2-oxobutyl) ester 
• 1093214-74-4 piperidine-4,4-dicarboxylic acid 4-benzyl 4-(3,3-dimethyl-2-oxobutyl) ester hydrochloride 
• 951744-99-3 benzyl 1-tert-butoxycarbonyl-4-thiocarbamoyl-4-piperidinecarboxylate 
• 951744-87-9 benzyl 1-tert-butoxycarbonyl-4-carbamoyl-4-piperidinecarboxylate 
• 951744-80-2 (1,2-bis(4-methoxyphenyl)-2-oxoethyl) 4-benzyloxycarbonyl-1-tert-butoxycarbonyl-4-piperidinecarboxylate 

Relevant academic research and scientific papers

UREIDE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

This invention relates to a pharmaceutical comprising, as an active ingredient, a ureide derivative represented by formula: or a pharmaceutically acceptable salt thereof. The ureide derivative or a pharmaceutically acceptable salt thereof according to the present invention is useful for relieving pain and treating or preventing neuropathic pain.

NOVEL DICARBOXYLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS

The present invention relates to new compounds of formula (I) possessing agonistic activity at sphingosine-1 -phosphate (S1 P) receptors, their process of preparation and their use as immunosuppressive agents. The invention is also directed to pharmaceutical compositions containing these compounds and use of these compounds for treatment/prevention of immune mediated diseases and conditions or inflammatory diseases and conditions.